Kathy LeeAssociate Chief, Laboratory of Biochemistry FDA
Bill LambertFellow, Drug Delivery and Device Development MedImmune
Edmond IsraelskiDirector, Human Factors Abbvie
Li-Chun TsouAssociate Director Global Pharmaceutical Commercialization Technology Merck
The market for pre-filled syringes continues to grow healthily, but why is the field still held back by the same issues year after year? Component quality still isn’t consistent; package integrity is still proving tough to test robustly enough. Regulations on human factors and combination products are as unclear as ever.
The 3rd Annual Pre-Filled Syringes Summit, will bring together leaders from all areas of pre-filled syringe development, manufacturing and regulation. Together we will share and discuss ideas to help overcome the problems holding back progress. So join us to help uncover and develop practical, near term, solutions to solve them NOW.
With an agenda put together with the help of thought leaders from the FDA, Genentech, Pfizer, Amgen, Eli Lilly, Baxter, Sanofi, Novartis, Janssen, Hospira, GlaxoSmithKline and many more, the 3rd Annual Pre-filled Syringes Summit will dig deeper than any other meeting. You will leave with immediately actionable solutions to help get your pre-filled syringe projects moving in the right direction. Whether you need clarity on regulations, or want an opportunity to network and discuss the problems you currently face, The 3rd Annual Pre-Filled Syringes Summit is the only North American meeting this year that can truly deliver.
Who is this meeting for?
Pharma and Biotech companies currently or looking to implement pre-filled syringe projects.
Pre-Filled Syringe Device Manufacturers developing in-house pre-filled syringes for use by drug developers.
CMOs offering innovative pre-filled syringe manufacturing solutions, looking to partner with drug developers.
Fill/Finish Professionals providing contract pre-filled syringe packaging services.
Glass/Polymer Experts supplying materials for the development of safe and reliable parenteral delivery devices.
“It exceeded my expectations. The talks were high quality and the interaction among participants was excellent.” Genentech
“A great place to get the latest information and networking.” Pfizer
“Strong program, great speakers and a genuine focus on identifying solutions.” Novartis
“An excellent opportunity to find out what other Pharma are doing and what’s emerging. Very valuable."” AstraZeneca